HCW Biologics Inc (NASDAQ:HCWB) has a beta value of 0.72 and has seen 22.54 million shares traded in the recent trading session. The company, currently valued at $16.74M, closed the recent trade at $14.91 per share which meant it gained $9.7 on the day or 186.18% during that session. The HCWB stock price is -576.06% off its 52-week high price of $100.80 and 66.47% above the 52-week low of $5.00.
HCW Biologics Inc (NASDAQ:HCWB) trade information
Sporting 186.18% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the HCWB stock price touched $14.91 or saw a rise of 9.53%. Year-to-date, HCW Biologics Inc shares have moved -16.44%, while the 5-day performance has seen it change 123.20%. Over the past 30 days, the shares of HCW Biologics Inc (NASDAQ:HCWB) have changed 62.42%.
HCW Biologics Inc (HCWB) estimates and forecasts
The company’s shares have lost -11.78% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -100.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -29.55% over the past 5 years.
HCWB Dividends
HCW Biologics Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
The top two institutional holders are AVANTAX PLANNING PARTNERS, INC. with over 0.28 million shares worth more than $0.18 million. As of 2024-06-30, AVANTAX PLANNING PARTNERS, INC. held 0.751% of shares outstanding.
The other major institutional holder is HIGHTOWER ADVISORS, LLC, with the holding of over 0.18 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.12 million and represent 0.4857% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and iShares Trust-iShares Micro-Cap ETF . As of Mar 31, 2025 , the former fund manager holds about 0.31% shares in the company for having 3.49 shares of worth $56855.0 while later fund manager owns 970.0 shares of worth $15815.0 as of Mar 31, 2025 , which makes it owner of about 0.09% of company’s outstanding stock.
